Skip To Main Content

Importance of assessing key disease domains in EOE

WHY IS IT IMPORTANT TO ASSESS MULTIPLE DISEASE DOMAINS IN EoE?

         Outcomes from different disease domains may be discordant with one another14

  • Symptoms may persist and fibrotic changes may still occur despite histologic remission 9,15,16
  • Symptoms may not be present despite endoscopic and histologic evidence of inflammation3
  • Subtle esophageal findings of EoE may not be recognized by the less-experienced endoscopist and routine endoscopic findings alone may not detect sections of reduced luminal diameter and microscopic inflammation, thereby requiring additional histologic assessments 9,14,15,17,18
  • EoE specific QoL assessments may not correlate with mild forms of endoscopic features of EoE and basal layer hyperplasia, thus requiring confirmation from endoscopic and histologic findings 3

  Comprehensive assessment using symptoms and QoL, histology, and endoscopy, enables an individualized, patient-centric approach to the management of EoE7,9,11,15

*Symptoms image reprinted with permission from Springer Nature, Clinical Reviews in Allergy and Immunology, Gonsalves N, Eosinophilic Gastrointestinal Disorders, Vol. 57/No. 2, Copyright 2019. Endoscopy image reprinted with permission from Springer Nature, Nature Reviews Gastroenterology & Hepatology, Biedermann L and Straumann A, Mechanisms and clinical management of eosinophilic oesophagitis: an overview, Vol. 20/No. 2, Copyright 2023. Histology image reprinted from Bystrom J, O'Shea NR. Postgrad Med J. 2014;90(1063):282-289. This is an open access article under the CC BY-NC 3.0 license (https:// creativecommons.org/licenses/by-nc/3.0/legalcode).
*EoE, eosinophilic esophagitis; eos/hpf, eosinophils per high-power field; QoL, quality of life.
1. Gonsalves N. Clin Rev Allergy Immunol. 2019;57(2):272-285. 2. Lucendo AJ, et al. United European Gastroenterol J. 2017;5(3):335-358. 3. Safroneeva E, et al. Aliment Pharma Ther. 2015;42:1000-1010. 4. Hewett R, et al. Dis Esophagus. 2017;30(1):1-7. 5. Lucendo AJ, et al. United European Gastroenterol J. 2018;6(1):38-45. 6. Pokrzywinski RM, et al. Adv Ther. 2020;37:4458-4478. 7. Dellon ES, et al. Gastroenterology. 2022;163(1):59-76. 8. Biedermann L, Straumann A. Nat Rev Gastroenterol Hepatol. 2023;20(2):101-119. 9. Aceves SS, et al. Gastrointest Endosc. 2022;96(4):576-592.e1. 10. Bystrom J, O'Shea NR. Postgrad Med J. 2014;90(1063):282-289. 11. Ma C, et al. J Allergy Clin Immunol. 2022;149(2):659-670. 12. Lyons E, et al. Gastroenterology. 2019;157(2):275- 277. 13. Hirano I, Aceves SS. Gastroenterol Clin North Am. 2014;43(2):297-316. 14. Hirano I, et al. Gastroenterology. 2020;158:1776-1786. 15. von Arnim U, et al. Clin Gastroenterol Hepatol. 2022;S1542-3565(22)01185-5. 16. Safroneeva E, et al. Gastroenterology. 2016;150(3):581-590.e4. 17. Dellon ES, et al. Gastroenterology. 2018;155(4):1022-1033. 18. Lynch KL, et al. Clin Transl Gastroenterol. Published online January 5, 2023. doi: 10.14309/ctg.0000000000000564.